Whole Exome Sequencing Market Publication Month: Aug 2019 | Report Code: TIPRE00005519 | No. of Pages: 178 | Category: Biotechnology | Status: Published
Whole Exome Sequencing Market to 2025 - Global Analysis and Forecasts by Product (Intermittent Catheters, Urinary Bags, Male External Catheters, Bowel Management, Others); Applications (Spinal Cord Injury, Benign Prostate Hyperplasia, Others); and End Users (Long-Term Care Facilities, Hospitals, and Others)
E-Mail : sales@theinsightpartners.com
Whole Exome Sequencing Market Publication Month: Aug 2019 | Report Code: TIPRE00005519 | No. of Pages: 178 | Category: Biotechnology | Status: Published
Introduction:
The global Whole exome sequencing market accounted to US$ 755.68 Mn in 2018 and is expected to grow at a CAGR of 19.8% during the forecast period 2019 – 2027, to account to US$ 3,812.0 Mn by 2027. Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the biotechnology. The growth is driven by countries such as China, and India which are engaged in conducting several studies.
E-Mail : sales@theinsightpartners.com
Whole Exome Sequencing Market Publication Month: Aug 2019 | Report Code: TIPRE00005519 | No. of Pages: 178 | Category: Biotechnology | Status: Published
Reduction in Time and Cost for Sequencing The exon is part of a genome which is responsible for making 1 or 2 percent of the entire genome of a person. All of the exon in a genome are together known as the exome. And thus, sequencing is of these is known as whole-exome sequencing. The whole-exome sequencing allows identifying the variations in the protein-coding sites of any gene compared to sequencing a few genes together. The whole-exome sequencing is preferred widely due to its property to identify a mutation in a single exon. Identifying mutation in at the original site makes whole-exome sequencing an efficient method and enable to identify possible disease-causing mutation. The advancement in the field of genomics has led to a significant reduction in the time and cost of genome sequencing. The related cost of sequencing with different sequencing techniques and strategies are of interest as they influence the scope and scale of the genomic research studies. Thus, it makes whole-exome sequencing much-preferred method than whole-genome sequencing. The advantages of exome sequencing have resulted in the reduction of time and cost to a great extent. Approximately 2% of the genome is sequenced by the WES method; however, it generally sequences the exon at a deeper level it sequence to 100X. The technique enables sequencing through a process where the DNA and RNA are hybridized with the protein-coding site and is isolated from the non-coding site. Also, the data required for 100X sequencing is approximately 5- 6GB, whereas, in genome sequencing, it is nearly 90GB. Thus, these factors offer lower data storage, faster, cheaper, and more accessible data analysis. Therefore, owing to the above-mentioned factors, it is estimated that the market for whole-exome sequencing is likely to grow significantly during the forecast period.
E-Mail : sales@theinsightpartners.com
Whole Exome Sequencing Market Publication Month: Aug 2019 | Report Code: TIPRE00005519 | No. of Pages: 178 | Category: Biotechnology | Status: Published
Rising Need of Molecular Diagnosis The whole-exome sequencing has been accepted as an advanced sequencing technique due to its advantages. Due to the benefits of whole-exome sequencing, it is used as a diagnostic tool in regular practice. The technique is mainly used to diagnose genetic diseases and cancer. The use of exome sequencing is offered genetic analysis that allows appropriate treatment, management, inheritance, and efficient decision making. The whole-exome sequencing technique is used as it provides information on clinically covered all genes. The technique analyzes conditions for single gene and multi gene disorders. The whole-exome sequencing technique is considered ideal for targeted management of complex conditions such as epilepsy, ASDs, neuropathy, and other genetic diseases. In addition, the whole-exome sequencing allows complete analysis of nearly 23,000 genes in the human genome with the help of nextgeneration sequencing in a single run. The whole-exome sequencing is a short-term substitute for receiving an image of a genome that is being coded. Whole-exome sequencing is attractive in the fields of research, diagnostics, and clinical setting. The whole-exome sequencing is used for identifying variants in both all the disease types and in SNPs associations and pharmacogenetics. Thus, the wide application of the whole-exome sequencing in the field of molecular diagnostics and clinical diagnostics are likely to influence the growth of the market during the forecast period.
E-Mail : sales@theinsightpartners.com
Whole Exome Sequencing Market Publication Month: Aug 2019 | Report Code: TIPRE00005519 | No. of Pages: 178 | Category: Biotechnology | Status: Published
The List of Companies 1.Thermo Fisher Scientific Inc. 2.Illumina, Inc. 3.Centogene AG 4.F. Hoffmann-La Roche AG 5.Psomagen, Inc. (previuosly Macrogen Corp.) 6.Pacific Biosciences of California, Inc. 7.Brooks Automation, Inc. (GENEWIZ, Inc.) 8.Bio-Rad Laboratories, Inc. 9.Eurofins Scientific 10.Stratos Genomics
Get Sample PDF Brochure
E-Mail : sales@theinsightpartners.com